Inclusion Criteria:  Patients with prostate carcinoma. Patients with Benign Prostatic Hyperplasia. Male subjects older that 50 years without prostate or neoplastic diseases.  Exclusion Criteria:  Male subjects younger that 50 years without prostate disease. Male subjects with neoplastic diseases either than prostate.